NewMediaWire distributes press releases on behalf of hundreds of publicly traded companies, as well as private corporations, non-profits and other public sector organizations. Founded and staffed by industry veterans, we offer a full complement of services including specialized delivery to financial sites and posting of photos and multimedia content. In addition, NewMediawire offers international and specialized services such as IR websites and industry specific distribution.
RSS Feed for NewMediaWireNovember 4, 2025 — VANCOUVER, BC - November 4, 2025 (NEWMEDIAWIRE) - Golden Cariboo Resources Ltd. (the “Company”) (CSE:GCC) (OTC:GCCFF) (WKN:A402CQ) (FSE:3TZ) announces the launch of its autumn surface drilling campaign at the Company’s flagship Quesnelle Gold Quartz Mine Property (the “Property”), located approximately 4 kilometers northeast of Hixon, British Columbia.
November 3, 2025 — MUNICH - November 3, 2025 (NEWMEDIAWIRE) - TTL Beteiligungs- und Grundbesitz-AG ("TTL AG") invites its shareholders to an extraordinary Annual General Meeting on December 9, 2025. The invitation to the Annual General Meeting was published in the Federal Gazette on October 31, 2025, in accordance with the statutory provisions.
November 3, 2025 — BERLIN - November 3, 2025 (NEWMEDIAWIRE) - The Supervisory Board of Medios AG has appointed Thomas Meier as a member of the Executive Board with effect from February 1, 2026, and designated him the new Chief Executive Officer (CEO) of the Company. He succeeds Matthias Gaertner, who will remain in office until December 31, 2025.
November 3, 2025 — Objective responses and promising anti-tumor activity observed in several patients across multiple cohorts in the ongoing Phase I/IIa clinical trial Data reinforces the therapeutic potential and safety profile of HDP-101 in relapsed or refractory multiple myeloma. R&D Webinar to be hosted on 11 November 2025 at 05:00 pm CET (08:00 am PST) LADENBURG, Germany - November 3, 2025 (NEWMEDIAWIRE) - Heidelberg Pharma AG (FSE: HPHA), a clinical-stage developer of innovative Antibody Drug Conjugates (ADCs), today announced the presentation of new clinical data from its ongoing Phase I/IIa clinical study evaluating its lead Amanitin-based ADC candidate, HDP-101 (INN: pamlectabart tismanitin), at the 16th Annual World ADC Congress, taking place in San Diego, California, from 3 to 6 November 2025.
November 3, 2025 — Fast-Acting, Discreet, and Precise HUGS Breath Spray Delivers 3mg THC Per Pump in a Refreshing Mint Flavor VIENNA, MISSOURI - November 3, 2025 (NEWMEDIAWIRE) - OG Yields, owned by Hippos, LLC, Missouri’s premier producer of cannabis cultivated in the heart of the Ozarks, today announced the launch of Missouri’s first and only cannabis breath spray, expanding its award-winning HUGS wellness line. The new HUGS Breath Spray is a fast-acting, discreet, and portable product offering precise dosing and consistent effects.
November 3, 2025 — By Meg Flippin Benzinga DETROIT, MICHIGAN - November 3, 2025 (NEWMEDIAWIRE) - As the markets enter the final stretch of 2025, investors are facing a high-stakes mix of macro uncertainty, sector rotation and elevated volatility. That calls for a protective stance, but traders can also use that volatility to their advantage.
November 3, 2025 — LOS ANGELES, CA - November 3, 2025 (NEWMEDIAWIRE) - Datavault AI (NASDAQ: DVLT), a pioneer in AI-powered data valuation and tokenization, today announced plans for the 2026 Dream Bowl Draft, which will select top invitees for the Crusaders vs. Patriots matchup in the Dream Bowl presented by Scilex on Jan.
November 3, 2025 — DALLAS, TX - November 3, 2025 (NEWMEDIAWIRE) - People living with aortic stenosis (AS) could gain earlier access to innovative care and treatment thanks to a new effort from the American Heart Association designed to boost clinical trial participation and speed diagnosis of this common but underdiagnosed heart valve condition. AS is characterized by the narrowing of the aortic valve opening, which restricts blood flow from the heart to the body.
November 3, 2025 — By Johnny Rice, Benzinga DETROIT, MICHIGAN - November 3, 2025 (NEWMEDIAWIRE) - Chia-Lin Simmons, CEO of LogicMark (OTC: LGMK), was recently interviewed by Benzinga. LogicMark is a leading provider of personal emergency response systems (PERS), health communications devices and IoT technologies, within a Connected Care Platform.
November 3, 2025 — By Johnny Rice, Benzinga DETROIT, MICHIGAN - November 3, 2025 (NEWMEDIAWIRE) - Chia-Lin Simmons, CEO of LogicMark (OTC: LGMK), was recently a guest on Benzinga’s All-Access. LogicMark is a leading provider of personal emergency response systems (PERS), health communications devices and IoT technologies to create a connected care platform.
November 3, 2025 — Relocations Strengthen Ties to Georgia’s Bio-Ecosystem and Position GeoVax for Late-Stage Development and Market Readiness ATLANTA, GA - November 3, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and multi-antigen vaccines against cancers and infectious diseases, today announced relocations of its corporate headquarters and laboratory operations to new facilities in the Atlanta metropolitan area.
November 3, 2025 — SILICON VALLEY, CA - November 3, 2025 (NEWMEDIAWIRE) - ABVC BioPharma, Inc.. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing therapeutic solutions in central nervous system (CNS), ophthalmology, and oncology/hematology indications, today announced its financial results for the quarter ended September 30, 2025, and provided an update on recent corporate developments.
November 3, 2025 — Milestone Caps a Strong October That Included Surpassing 100,000 Pounds of Rubber Shipments and Expanded Ecosystem Partnerships DETROIT, MI - November 3, 2025 (NEWMEDIAWIRE) - One World Products, Inc. (OTC: OWPC), soon to be renamed Isiah Enterprises, announced that a major automotive OEM has approved the company’s cellulose fiber-filled masterbatch for use in near-future vehicle models.
November 3, 2025 — Research Highlights: Initiating CPR within the first five minutes after cardiac arrest can nearly double the chances of survival for children, according to preliminary research analyzing data for more than 10,000 children from a U. S.
November 3, 2025 — Research Highlights: People with a condition in which protein build up stiffens heart walls – called transthyretin amyloid cardiomyopathy – were more likely to have a stroke if they also had a mechanical malfunction in the atrial chamber of their heart. A noninvasive risk assessment tool may help identify people with the condition who are at high stroke risk and might benefit from preventive measures, according to researchers.
November 3, 2025 — VANCOUVER, BC - November 3, 2025 (NEWMEDIAWIRE) - Ares Strategic Mining Inc. (CSE: ARS) (OTC: ARSMF) (FRA: N8I1) is pleased to announce the successful completion and activation of its secondary underground ventilation system at the Lost Sheep Fluorspar Mine in Juab County, Utah.
November 3, 2025 — Research Highlights: Optimal cardiovascular health, based on the American Heart Association’s Life’s Essential 8 metrics, may decrease the risk of mild cognitive impairment and dementia for adults with Type 2 diabetes. Among adults with both Type 2 diabetes and a high genetic risk for dementia, researchers found that having moderate or high cardiovascular health, compared to having low cardiovascular health, greatly lowered the risk of developing mild cognitive impairment and dementia over 13 years.
November 3, 2025 — Research Highlights: For people with Type 2 diabetes, following at least six healthy lifestyle habits when taking GLP-1 RA medications can lower their risk of heart attack, stroke, hospital visits due to cardiovascular disease and death, more than medication alone or healthy lifestyle changes alone. A study of more than 63,000 military veterans with Type 2 diabetes who took GLP-1 RA medications found that those with at least six healthy lifestyle habits had a 50% lower risk of serious cardiovascular events when compared to veterans with a lower adherence to a healthy lifestyle who were receiving standard diabetes care but not taking GLP-1 RA medication.
November 3, 2025 — Research Highlights: A review of 5 years of health records for more than 130,000 adults with insomnia who had used melatonin for at least a year found they were more likely to be diagnosed with heart failure, require hospitalization for the condition or die from any cause. The association between melatonin and increased risk of heart failure or death found in this study, which cannot prove a cause-and-effect relationship, raises safety concerns about the use of melatonin, which is widely available, and may warrant more research on melatonin to assess its cardiovascular safety, researchers said.
November 3, 2025 — Research Highlights: Adults with Type 2 diabetes (T2D) and at moderate or high risk of cardiovascular disease who took low-dose aspirin were less likely to experience a serious cardiovascular event, including a heart attack, stroke or death, than peers who did not take aspirin. Any low-dose aspirin use was associated with significantly lower risk of having a heart attack or stroke compared to no low-dose aspirin use, with greater benefit observed among those individuals who took it the most often.